Predictive Oncology Stock Price History
| POAI Stock | USD 1.62 0.14 9.46% |
Below is the normalized historical share price chart for Predictive Oncology extending back to April 09, 2010. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Predictive Oncology stands at 1.62, as last reported on the 18th of February 2025, with the highest price reaching 1.62 and the lowest price hitting 1.47 during the day.
If you're considering investing in Predictive Stock, it is important to understand the factors that can impact its price. Predictive Oncology is extremely dangerous given 3 months investment horizon. Predictive Oncology maintains Sharpe Ratio (i.e., Efficiency) of 0.19, which implies the firm had a 0.19 % return per unit of risk over the last 3 months. We were able to analyze thirty different technical indicators, which can help you to evaluate if expected returns of 2.05% are justified by taking the suggested risk. Use Predictive Oncology Coefficient Of Variation of 628.53, semi deviation of 5.66, and Risk Adjusted Performance of 0.122 to evaluate company specific risk that cannot be diversified away.
As of now, Predictive Oncology's Common Stock Total Equity is decreasing as compared to previous years. The Predictive Oncology's current Common Stock Shares Outstanding is estimated to increase to about 4.8 M, while Total Stockholder Equity is projected to decrease to under 5 M. . The Predictive Oncology's current Price Earnings To Growth Ratio is estimated to increase to 0.03, while Price To Sales Ratio is projected to decrease to 8.11. Predictive Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 29th of January 2018 | 200 Day MA 1.0722 | 50 Day MA 1.1601 | Beta 1.258 |
Predictive |
Sharpe Ratio = 0.1904
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | POAI | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 10.77 actual daily | 95 95% of assets are less volatile |
Expected Return
| 2.05 actual daily | 40 60% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 14 86% of assets perform better |
Based on monthly moving average Predictive Oncology is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Predictive Oncology by adding it to a well-diversified portfolio.
Price Book 5.4934 | Enterprise Value Ebitda (0.51) | Price Sales 7.2771 | Shares Float 6.6 M | Wall Street Target Price 3 |
Predictive Oncology Stock Price History Chart
There are several ways to analyze Predictive Stock price data. The simplest method is using a basic Predictive candlestick price chart, which shows Predictive Oncology price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 6, 2025 | 1.89 |
| Lowest Price | November 19, 2024 | 0.64 |
Predictive Oncology February 18, 2025 Stock Price Synopsis
Various analyses of Predictive Oncology's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Predictive Stock. It can be used to describe the percentage change in the price of Predictive Oncology from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Predictive Stock.| Predictive Oncology Price Daily Balance Of Power | 0.93 | |
| Predictive Oncology Price Action Indicator | 0.15 | |
| Predictive Oncology Price Rate Of Daily Change | 1.09 |
Predictive Oncology February 18, 2025 Stock Price Analysis
Predictive Stock Price History Data
The price series of Predictive Oncology for the period between Wed, Nov 20, 2024 and Tue, Feb 18, 2025 has a statistical range of 1.25 with a coefficient of variation of 32.7. The price distribution for the period has arithmetic mean of 1.06. The median price for the last 90 days is 0.86. The company completed stock split (1:20) on 24th of April 2023. Predictive Oncology had dividends distributed to its stock-holders on 2019-10-29.| Open | High | Low | Close | Volume | ||
02/18/2025 | 1.48 | 1.62 | 1.47 | 1.62 | ||
| 02/14/2025 | 1.48 | 1.62 | 1.47 | 1.62 | 308,880 | |
| 02/13/2025 | 1.50 | 1.59 | 1.40 | 1.48 | 332,996 | |
| 02/12/2025 | 1.40 | 1.47 | 1.37 | 1.46 | 134,600 | |
| 02/11/2025 | 1.42 | 1.44 | 1.40 | 1.40 | 93,917 | |
| 02/10/2025 | 1.44 | 1.47 | 1.39 | 1.43 | 182,400 | |
| 02/07/2025 | 1.47 | 1.51 | 1.41 | 1.45 | 182,842 | |
| 02/06/2025 | 1.52 | 1.57 | 1.50 | 1.53 | 167,162 | |
| 02/05/2025 | 1.49 | 1.58 | 1.46 | 1.51 | 266,428 | |
| 02/04/2025 | 1.37 | 1.51 | 1.37 | 1.50 | 178,400 | |
| 02/03/2025 | 1.42 | 1.52 | 1.36 | 1.39 | 235,900 | |
| 01/31/2025 | 1.60 | 1.61 | 1.43 | 1.47 | 328,700 | |
| 01/30/2025 | 1.44 | 1.64 | 1.42 | 1.55 | 587,600 | |
| 01/29/2025 | 1.36 | 1.48 | 1.36 | 1.44 | 173,800 | |
| 01/28/2025 | 1.38 | 1.42 | 1.33 | 1.39 | 279,600 | |
| 01/27/2025 | 1.42 | 1.45 | 1.34 | 1.39 | 391,900 | |
| 01/24/2025 | 1.50 | 1.60 | 1.41 | 1.47 | 685,700 | |
| 01/23/2025 | 1.46 | 1.65 | 1.41 | 1.43 | 1,533,006 | |
| 01/22/2025 | 1.58 | 2.37 | 1.31 | 1.48 | 48,341,238 | |
| 01/21/2025 | 1.18 | 1.29 | 1.16 | 1.27 | 223,896 | |
| 01/17/2025 | 1.34 | 1.38 | 1.19 | 1.21 | 323,619 | |
| 01/16/2025 | 1.20 | 1.42 | 1.20 | 1.34 | 1,602,183 | |
| 01/15/2025 | 1.26 | 1.27 | 1.16 | 1.19 | 249,404 | |
| 01/14/2025 | 1.28 | 1.34 | 1.19 | 1.20 | 242,278 | |
| 01/13/2025 | 1.37 | 1.37 | 1.23 | 1.28 | 224,731 | |
| 01/10/2025 | 1.30 | 1.47 | 1.07 | 1.36 | 740,226 | |
| 01/08/2025 | 1.58 | 1.58 | 1.25 | 1.34 | 923,986 | |
| 01/07/2025 | 1.98 | 2.25 | 1.63 | 1.69 | 2,466,971 | |
| 01/06/2025 | 1.71 | 3.06 | 1.37 | 1.89 | 54,875,039 | |
| 01/03/2025 | 0.95 | 1.53 | 0.89 | 1.20 | 3,950,969 | |
| 01/02/2025 | 0.84 | 0.94 | 0.84 | 0.92 | 122,735 | |
| 12/31/2024 | 0.91 | 0.97 | 0.77 | 0.82 | 261,008 | |
| 12/30/2024 | 0.97 | 0.99 | 0.82 | 0.90 | 255,941 | |
| 12/27/2024 | 0.96 | 0.99 | 0.89 | 0.99 | 466,236 | |
| 12/26/2024 | 0.74 | 0.89 | 0.74 | 0.86 | 347,654 | |
| 12/24/2024 | 0.69 | 0.75 | 0.69 | 0.75 | 70,995 | |
| 12/23/2024 | 0.70 | 0.70 | 0.66 | 0.69 | 79,704 | |
| 12/20/2024 | 0.71 | 0.71 | 0.68 | 0.69 | 20,636 | |
| 12/19/2024 | 0.73 | 0.75 | 0.68 | 0.72 | 32,230 | |
| 12/18/2024 | 0.73 | 0.76 | 0.71 | 0.73 | 32,476 | |
| 12/17/2024 | 0.74 | 0.74 | 0.69 | 0.72 | 94,606 | |
| 12/16/2024 | 0.80 | 0.80 | 0.73 | 0.75 | 80,847 | |
| 12/13/2024 | 0.79 | 0.79 | 0.76 | 0.78 | 54,823 | |
| 12/12/2024 | 0.80 | 0.82 | 0.78 | 0.79 | 53,407 | |
| 12/11/2024 | 0.84 | 0.84 | 0.79 | 0.79 | 73,742 | |
| 12/10/2024 | 0.82 | 0.88 | 0.78 | 0.83 | 275,291 | |
| 12/09/2024 | 0.82 | 0.82 | 0.77 | 0.80 | 88,950 | |
| 12/06/2024 | 0.80 | 0.82 | 0.74 | 0.80 | 149,873 | |
| 12/05/2024 | 0.78 | 0.78 | 0.70 | 0.76 | 73,615 | |
| 12/04/2024 | 0.83 | 0.83 | 0.72 | 0.74 | 166,324 | |
| 12/03/2024 | 0.81 | 0.84 | 0.78 | 0.82 | 63,693 | |
| 12/02/2024 | 0.79 | 0.83 | 0.77 | 0.82 | 83,711 | |
| 11/29/2024 | 0.79 | 0.81 | 0.75 | 0.81 | 49,305 | |
| 11/27/2024 | 0.79 | 0.83 | 0.77 | 0.78 | 82,212 | |
| 11/26/2024 | 0.76 | 0.85 | 0.75 | 0.80 | 249,196 | |
| 11/25/2024 | 0.79 | 0.79 | 0.73 | 0.75 | 99,068 | |
| 11/22/2024 | 0.69 | 0.75 | 0.69 | 0.72 | 43,084 | |
| 11/21/2024 | 0.68 | 0.69 | 0.66 | 0.69 | 37,639 | |
| 11/20/2024 | 0.65 | 0.66 | 0.62 | 0.65 | 76,465 | |
| 11/19/2024 | 0.66 | 0.69 | 0.62 | 0.64 | 77,244 | |
| 11/18/2024 | 0.70 | 0.72 | 0.67 | 0.68 | 32,494 |
About Predictive Oncology Stock history
Predictive Oncology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Predictive is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Predictive Oncology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Predictive Oncology stock prices may prove useful in developing a viable investing in Predictive Oncology
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 4.6 M | 4.8 M | |
| Net Loss | -23.2 M | -24.3 M |
Predictive Oncology Stock Technical Analysis
Predictive Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
| All Next | Launch Module |
Predictive Oncology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Predictive Oncology's price direction in advance. Along with the technical and fundamental analysis of Predictive Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Predictive to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.122 | |||
| Jensen Alpha | 1.64 | |||
| Total Risk Alpha | 1.63 | |||
| Sortino Ratio | 0.2336 | |||
| Treynor Ratio | 2.19 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Predictive Stock analysis
When running Predictive Oncology's price analysis, check to measure Predictive Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Predictive Oncology is operating at the current time. Most of Predictive Oncology's value examination focuses on studying past and present price action to predict the probability of Predictive Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Predictive Oncology's price. Additionally, you may evaluate how the addition of Predictive Oncology to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |